
Sign up to save your podcasts
Or


Jef Akst, managing editor at BioSpace, talks about the major CGT issues she's been covering at #ASGCT2024 including regulatory considerations and AAV manufacturing. She also tells host Lynnea Olivarez what she hopes to be reporting on next year at the ASGCT Annual Meeting in New Orleans!
Show your support for ASGCT!: https://asgct.org/membership/donate
See omnystudio.com/listener for privacy information.
By American Society of Gene & Cell Therapy4.9
1616 ratings
Jef Akst, managing editor at BioSpace, talks about the major CGT issues she's been covering at #ASGCT2024 including regulatory considerations and AAV manufacturing. She also tells host Lynnea Olivarez what she hopes to be reporting on next year at the ASGCT Annual Meeting in New Orleans!
Show your support for ASGCT!: https://asgct.org/membership/donate
See omnystudio.com/listener for privacy information.

38,504 Listeners

30,795 Listeners

43,657 Listeners

38,757 Listeners

3,438 Listeners

767 Listeners

826 Listeners

6,426 Listeners

9,559 Listeners

321 Listeners

6,561 Listeners

34 Listeners

21 Listeners

38 Listeners

50 Listeners